Cargando…
Injectable hydrogel particles for amorphous solid formulation of biologics
The fast pace of breakthroughs in cancer immunotherapy, combined with the new paradigm of moving toward high-concentration dosages and combinatorial treatments, is generating new challenges in the formulation of biologics. To address these challenges, we describe a method of formulation that enables...
Autores principales: | Erfani, Amir, Reichert, Paul, Narasimhan, Chakravarthy N., Doyle, Patrick S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428138/ https://www.ncbi.nlm.nih.gov/pubmed/37593455 http://dx.doi.org/10.1016/j.isci.2023.107452 |
Ejemplares similares
-
Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
por: Dharani, Sathish, et al.
Publicado: (2022) -
Injectable Amorphous Chitin-Agarose Composite Hydrogels for Biomedical Applications
por: Priya, Murali Vishnu, et al.
Publicado: (2015) -
Utilizing Drug Amorphous Solid Dispersions for the Preparation of Dronedarone per os Formulations
por: Kapourani, Afroditi, et al.
Publicado: (2023) -
Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018) -
Amorphous-Amorphous Phase Separation in API/Polymer Formulations
por: Luebbert, Christian, et al.
Publicado: (2017)